Anal fistula is a painful colorectal condition that affects hundreds of thousands of people worldwide 1
Patients endure a poor quality of life, experiencing pain, suffering and discharge from the tract and related abscesses.
Patients and their physicians are dissatisfied with current treatment options, which are not effective for curing anal fistula.
Current treatment options have poor results, with the risk of causing permanent incontinence, inadequate healing, and repeat surgeries.
There are 90,000 annual surgical procedures performed to treat anal fistula in the U.S. alone.2
The Signum Surgical BioHealx™ implant is a helical, barbed bioabsorbable implant that is placed to close an anal fistula at the internal opening by tissue apposition. The implant is placed using a pre-loaded, single-use, disposable delivery device that rotates the helical implant into the soft tissue surrounding the internal opening of fistula. Post delivery, the device is fully enclosed in tissue and is not exposed to the ano-rectal canal.
1. Ommer A et al: Clinical practice guideline: Cryptoglandular anal fistula. Dtsch Arztebl Int 2011; 108(42): 707–13. 2. Zanotti, C., Martinez-Puente, C., Pascual, I. et al. Int J Colorectal Dis (2007) 22: 1459